Substance / Medication

Erythritol tetranitrate

Overview

Active Ingredient
erythrityl tetranitrate
RxNorm CUI
4040

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Effects of pentaerythritol tetranitrate on endothelial function in coronary artery disease: results of the PENTA study.
Schnorbus Boris, Schiewe Robert, Ostad Mir Abolfazl et al. · Clin Res Cardiol · 2010
PMID: 19957087RCT
Two-electron reduction of quinones by Enterobacter cloacae PB2 pentaerythritol tetranitrate reductase: quantitative structure-activity relationships.
Miseviciene Lina, Anusevicius Zilvinas, Sarlauskas Jonas et al. · Acta Biochim Pol · 2007
PMID: 17546202Observational
Properties of Erythritol Tetranitrate from Molecular Dynamics Simulation.
Cawkwell M J, Manner V W · J Phys Chem C Nanomater Interfaces · 2024
PMID: 38595775OtherFull text (PMC)
Large-Scale Analysis on Accelerated Aging of Pentaerythritol Tetranitrate (PETN) Powders in Detonators.
Spielvogel Kyle D, Lease Nicholas, Brown Geoffrey W et al. · ACS Omega · 2024
PMID: 39072092OtherFull text (PMC)
Transport Properties of Liquid Pentaerythritol Tetranitrate (PETN) from Molecular Dynamics Simulations.
Perriot Romain, Cawkwell Marc J, Manner Virginia W · J Phys Chem B · 2024
PMID: 39535183OtherFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Eritrityl tetranitrate (substance)
SNOMED CT
62368002
UMLS CUI
C0014758
RxNorm CUI
4040

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.